Pages that link to "Q39876003"
Jump to navigation
Jump to search
The following pages link to Protein scaffold and expression level determine antiviral activity of membrane-anchored antiviral peptides (Q39876003):
Displaying 10 items.
- Survival of the fittest: positive selection of CD4 T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection (Q28749863) (← links)
- Protection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection (Q33514823) (← links)
- Computational models of HIV-1 resistance to gene therapy elucidate therapy design principles (Q33658642) (← links)
- Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo (Q35182775) (← links)
- Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus (Q36195192) (← links)
- Mutations in gp120 contribute to the resistance of human immunodeficiency virus type 1 to membrane-anchored C-peptide maC46. (Q37192248) (← links)
- Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir (Q38777005) (← links)
- Secreted antiviral entry inhibitory (SAVE) peptides for gene therapy of HIV infection (Q39583562) (← links)
- Cell and Gene Therapy for HIV Cure (Q47236016) (← links)
- A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus (Q92964715) (← links)